We use evidence based design to solve unmet clinical challenges
We are a world-leading clinical design team who have won multiple awards
We specialise in developing extremity orthopaedic technologies
We strive to improve the lives of patients with our revolutionary technologies
Loci Orthopaedics and the InDx ® device originated from the BioInnovate program, a structured medical device innovation program in Ireland with proven outcomes. Loci Orthopaedics is based at the Business Innovation Centre in the National University of Ireland Galway.
John has over decade working within the medical device sector with extensive experience in the design, development, and production of medical devices. A strong experience core earned through working in small start-ups and large multinational companies, throughout each stage of the development life cycle. John has worked within and led various functions including R&D, Process Development, Supply Chain, Manufacturing, Quality, Regulatory – 510(k) & CE Mark approvals, Clinical, Marketing & Commercial Clinical Use. He has held roles of increasing responsibility with companies including Novate Medical, Creganna Medical, Boston Scientific. This journey culminated in Vetex Medical where he was part of leadership team that successfully exited in 2021. As VP Technical Operations, John’s wide ranging technical and leadership skillset with full product and company life cycle experience are paramount to the successful operations of Loci Orthopaedics.
Karin brings nearly two decades of experience in the medical field and over a decade of leadership in medical affairs, clinical development, and regulatory strategy. A veterinarian by training, she previously served as Vice President of Medical Affairs and Product Strategy at BlueWind Medical, where she led multinational clinical programs across 25+ sites, guided FDA submissions, and drove publication and regulatory strategies in collaboration with global experts. Karin holds a PhD in Epidemiology from the Hebrew University.
Dr. Bolger has 40 years of pharmaceutical industry experience in management roles across R&D, Commercial and Business Development (BD) and Venture Investments. She spent 11 years in Licensing and Acquisition (L&A), including Global Head of Scientific Licensing for Johnson & Johnson’s Pharmaceutical business, and before that as Director in the Business Development group at GlaxoSmithKline. Dr Bolger spent over 10 years (2012-2022) as Vice President Venture Investment in J&J’s corporate venture fund, Johnson & Johnson Innovation – JJDC. She represented JJDC on the Board of Directors of over a dozen companies, including Aelix Therapeutics, Asceneuron SA, Aviado Bio, Biocartis, Calypso Biotech, Inivata, Merus, Pulmocide, S-Biomedic, Syndesi, T-Rex. Dr Bolger also represented JJDC’s LP investments in multiple Venture Capital Funds in UK and Europe as well as representing J&J’s interests in other funding vehicles including incubators and accelerators. As an independent consultant since 2022, Jeanne has taken up a number of Board / Chair roles including Exevir BV (Chair), Astrivax NV (Chair), S-Biomedic, Sapreme Technologies BV (Chair), Life Healthcare Group (JSE:LSE) and Quibim AI. She is also a Venture Partner with Seroba VC. Jeanne runs a consulting practice, advising biotechnology and pharmaceutical companies in fund-raising and business development and in structuring and operating corporate venture funds.
Dr Brendan BolandBrendan graduated with honours from University College Dublin Medical School in 2006. As a post-graduate, he became a Member of the Royal College of Physicians of Ireland and also a member of the Irish College of General Practitioners. Brendan was a Fellow of the Class of 2014 on the prestigious BioInnovate Ireland Fellowship. Skilled at identifying and determining opportunities in the lifescience and health technology landscapes, he uses his medical and business training to critically appraise very early-stage development opportunities and de-risk potential investment opportunities. As a co-founder of Loci Orthopaedics, Brendan was responsible for the company’s overall commercial and clinical strategy. He led the company’s funding efforts, raising over EUR16M to date in a mix of grant and equity funding. Brendan is also a named inventor on six granted US patents and the leader in bringing the company’s primary product to clinical trials. As Executive Chairperson, Brendan maintains an active role in the company, optimising the company’s overall business strategy to successfully bring novel technologies to market to meet large unmet clinical needs.
Daniel O’MahonyDaniel O’Mahony is a Partner at Seroba Life Sciences venture capital fund and brings a wealth of experience from pharma and medtech industry in product development, clinical trials, product commercialisation, strategic planning, licensing, corporate venturing, technology commercialisation and venture capital investment. He held senior appointments at Elan Corporation plc from 1994-2003, where he was involved in technology and product development and in corporate venturing. He established the Technology Transfer Office at NUI Galway in 2005. Daniel graduated with a Ph.D. from University College Cork, holds a business degree in technology management from the Smurfit Business School, University College Dublin and has held academic appointments in Ireland and USA. He currently sits on a number of boards including Perfuze, Loci Orthopaedics, Carballo Group Limited and ATXA Therapeutics. He previously sat on the boards of PQ Bypass (acquired by Endologix), Novate Medical (acquired by BTG), Apica Cardiovascular (acquired by Thoratec), Covagen (acquired by Cilag/Janssen Pharmaceutical Companies of the Johnson & Johnson Group), Atlantic Therapeutics (acquired by Caldera Medical inc), Stokes Bio (acquired by Life Technologies), Straatum (acquired by Lam Research Corporation). Seroba is currently investing from its new fund, Fund IV with a focus in pharma /biotech and medtech investments. He has published in several scientific journals and is co-inventor on numerous patent families.
Dr. Anton CliffordAnton brings extensive experience in company development, product creation, commercialization and customer relationship management. Uniquely suited to Loci Orthopaedics mission, Anton’s experience of bringing a novel orthopedics product from concept, through US regulatory approval, and into a pivotal US-based clinical trial, will be directly applicable to our future here at Loci. His in-depth technical knowledge will complete an outstanding combination of clinical and commercial acumen that is directly applicable to Loci Orthopaedics. Anton is co-founder and CEO of MoxiMed, an orthopaedics medical device company. He has been a key member of the MoxiMed team that has brought a product from concept to clinical use.
Gerry has worked consistently in medical devices and diagnostics since the late 1970s, spending ten years in the USA industry sector during that time. He has had a number of increasingly responsible technical roles within Technicon, Sherwood Medical and C.R. Bard/Medtronic, most recently that of senior engineering manager within R&D at Medtronic. His expertise lies in process development, new technology investigation and product design methodologies. He has several patents and trade secrets to his credit and has been charged with IP development at leadership level. A believer in team synergy, he is passionate about innovation that occurs at the boundaries of diverse disciplines. Gerry was a BioInnovate Ireland Fellow 2014, during which he further developed his skills at identifying unmet clinical needs and finding solutions through the application of experience and good engineering practice.
Dr. Amy LaddDr. Ladd is one of the world’s leading experts in the biomechanics and kinematics of the thumb base joint. She was a fellow at L'Institut de la Main in Paris, France prior to joining the Stanford University faculty in 1990.
Dr. Peter WeissDr. Weiss is an internationally recognised orthopaedic hand surgeon. He specialises in hand and wrist reconstruction with a special interest in finger and wrist joint replacement surgery.
Prof. Filip StockmansProf Stockmans has numerous peer-reviewed journal articles and book chapters on hand and thumb base joint surgery. He is one of the most prolific thumb base joint implant users in the world, with the best clinical outcomes recorded and studied of any European hand surgeon.
Prof. Marco RittProf. Ritt is a professor of plastic surgery specialising in hand surgery at Amsterdam University Medical Center. He is also co-founder of The Hand Clinic, the first private clinic for hand and wrist surgery and therapy in the Netherlands.
Block 3 Corporate House,
Ballybrit Business Park,
Galway,
H91 KT67
+353 (0)91 123454
